| Value | ₹95.30 Cr |
|---|
BSE filing, NSE: HTMEDIA. Summary written from the filing by ALFA Finder's alert engine.
HT Media Ltd: key numbers
- Share price
- ₹22.52
- Market cap
- ₹524.1 Cr
- Revenue (annual)
- ₹1,803 Cr
- Net profit (annual)
- ₹-54.27 Cr
- P/E (TTM)
- -52.1×Sector 45.0×
- Promoter holding
- 69.50%+0.00% QoQ
- FII holding
- 0.03%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from HT Media Ltd
All →HT Media Board Meeting Date
HT Media Ltd notified BSE and NSE of a board meeting on 5 November 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. The trading window stays closed until 7 November 2026.
HT Media Other Announcement
HT Media Ltd has submitted its quarterly shareholding pattern under Regulation 31. This is a routine compliance filing reporting the company's equity distribution among various shareholders.
HT Media Debt & Borrowing
HT Media filed its half-yearly statement of outstanding debt securities as on September 30, 2026, as required by SEBI regulations.
HT Media Annual General Meeting
HT Media Limited concluded its 24th Annual General Meeting on September 25, 2026. Shareholders considered financial statements for FY26 and the re-appointment of directors.
HT Media Other Announcement
HT Media has dispatched letters to shareholders with unregistered e-mails, providing a web-link to the Annual Report for FY 2025-26 and the 24th AGM notice.
HT Media Annual General Meeting
HT Media Limited has issued a notice for its 24th Annual General Meeting, scheduled to be held on September 25, 2026, via video conferencing.
Other fund raise announcements
All →Rite Zone Chemcon India Fund Raise of ₹6.58 Cr
Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.
- Value
- ₹6.58 Cr
Sudarshan Pharma Industries Fund Raise of ₹72 Cr
Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.
- Value
- ₹72.00 Cr
Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr
Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.
- Value
- ₹68.20 Cr
Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.